Mechanistic view of risk factors for venous thromboembolism.
about
Elevated risk of venous thromboembolic events in patients with inflammatory myopathiesCritical appraisal of dabigatran in the treatment of deep vein thrombosis and pulmonary embolismShiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals.Recent Progress in Research on the Pathogenesis of Pulmonary Thromboembolism: An Old Story with New Perspectives.Enhanced pre-operative thrombolytic status is associated with the incidence of deep venous thrombosis in patients undergoing total knee arthroplastyIncreased promyelocytic-derived microparticles: a novel potential factor for coagulopathy in acute promyelocytic leukemia.Integrative bioinformatics links HNF1B with clear cell carcinoma and tumor-associated thrombosis.Ultrasound screening for deep venous thrombosis detection: a prospective evaluation of 200 plastic surgery outpatients.Study on relationships among deep vein thrombosis, homocysteine & related B group vitaminsAssociation between micro particle-tissue factor activity, factor VIII activity and recurrent VTE in patients with acute pulmonary embolism.New insights into the mechanisms of venous thrombosis.Pregnancy causes diminished myogenic tone and outward hypotrophic remodeling of the cerebral vein of Galen.Caprini Scores, Risk Stratification, and Rivaroxaban in Plastic Surgery: Time to Reconsider Our Strategy.Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.Association between B-group vitamins and venous thrombosis: systematic review and meta-analysis of epidemiological studies.Autoimmune diseases and venous thromboembolism: a review of the literature.Revisited role of microparticles in arterial and venous thrombosis.New insights into modulation of thrombin formation.The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen).Extracellular DNA and histones: double-edged swords in immunothrombosis.Pulmonary Embolism Following Outpatient Vasectomy.Idiopathic inflammatory myopathy and the risk of venous thromboembolism: a meta-analysis.Prevalence of common hereditary risk factors for thrombophilia in Somalia and identification of a novel Gln544Arg mutation in coagulation factor V.The efficacy of forceful ankle and toe exercises to increase venous return: A comprehensive Doppler ultrasound study.Comorbid risks of deep vein thrombosis and pulmonary thromboembolism in patients with chronic pancreatitis: a nationwide cohort study.Multiple sclerosis increases the risk of venous thromboembolism: a nationwide cohort analysis.Soluble P-selectin for the diagnosis of lower extremity deep venous thrombosis.Mast Cells Granular Contents Are Crucial for Deep Vein Thrombosis in Mice.Incidence of venous thromboembolism in a homebound population.Systemic lupus erythematosus increases the risks of deep vein thrombosis and pulmonary embolism: a nationwide cohort study.Economy class syndrome: what is it and who are the individuals at risk?Whole exome sequencing in thrombophilic pedigrees to identify genetic risk factors for venous thromboembolism.Optimization of quantitative proteomic analysis of clots generated from plasma of patients with venous thromboembolism.Antithrombin deficiency and decreased protein C activity in a young man with venous thromboembolism: a case report.Platelets Drive Thrombus Propagation in a Hematocrit and Glycoprotein VI-Dependent Manner in an In Vitro Venous Thrombosis Model.Comparative rheology of the adhesion of platelets and leukocytes from flowing blood: why are platelets so small?Procoagulant microparticles are increased in patients with Behçet's disease but do not define a specific subset of clinical manifestations.NMMHC IIA inhibition impedes tissue factor expression and venous thrombosis via Akt/GSK3β-NF-κB signalling pathways in the endothelium.Comparison of the serum metabolic signatures based on 1H NMR between patients and a rat model of deep vein thrombosis.Risk assessment of venous thrombosis in families with known hereditary thrombophilia: the MARseilles-NImes prediction model
P2860
Q26746904-3B8E49CD-43E2-44EC-AC1B-015F76453DC1Q26799691-A2BE66F4-4374-473D-9F10-06E82BC5A89DQ33404640-7F371C1F-D34D-446C-8E2B-9E94539804B1Q33581791-5ABFF135-E5A5-482B-B098-46EFCAF77D14Q33891630-63C6ED00-5DCE-4518-9206-90477EF7EDBAQ34560286-4B3C71A9-F6C5-46C1-8170-E53BEE83EC25Q34990141-7A816F7B-4BC8-47C2-8CBE-566DC16DB491Q35288266-1DCCA470-F5AE-4D80-BE5A-B32153D68F51Q35765965-74502D10-17D7-40D8-9CBC-9CD8A14276CBQ35987865-D2145ACC-300D-4B9B-BE5E-73D1D3746436Q36068279-103713D8-ECD5-4BE1-9C8F-42DB3C532822Q36745092-128576B3-1374-43C6-AF22-1F603EFC155EQ37116980-C01D71F1-EA64-47D6-AE18-65BEAB82ED52Q37169096-0A8085AD-8672-4614-9340-47747631811EQ38022447-5ACBA796-C7D1-4842-A026-5C4C31AB4CF0Q38039441-5AABE790-DCB6-4E22-AC66-BD01C5411465Q38117725-1A8B029D-CD22-4998-AA79-3345884609BDQ38136548-92B0001A-68DC-4772-9E25-A248E440A363Q38261764-55625D20-EDCD-4751-93D8-DA51B5B172C3Q38543321-EA0C108F-2900-463D-8437-B27477937CF2Q38779342-65055330-BCC8-48DB-9FEF-F83FB92F4779Q38792529-48864F23-9D0B-4BF0-BB2C-00FE93D88AC9Q40049106-CBD5F694-5316-4EB2-857A-36E585D2CCC7Q40212301-0A39A8FA-9E10-4E64-8C09-FA92997FEA56Q40326375-2E12D3E8-B1B7-479D-8859-FC780232ECC0Q40724475-AB25930E-9749-4B6A-9978-4771B1E0C3FCQ41884222-DDCFEB69-35D9-49E1-9002-F934E2A5C07FQ42368510-B57AA0A5-146D-4EB9-8D29-AD2990A19DC6Q43458764-0AE30E44-79B9-41A5-815D-8ECD5B6A098EQ43846279-3FD7FF37-DC0F-4855-B0AE-C2D394A2C0C3Q45900775-356C4E46-016E-4F90-A887-4B5969F3BE37Q47120217-11C311DE-1608-4685-BEED-C11FF6F13A27Q47134133-60940967-7024-477F-840A-002725C1AD57Q47871332-ED8A6ACE-2924-45AF-B2D7-2F97A39CBD4CQ50146003-8ACC3E3B-6983-4473-81FB-8AEBCEDD3481Q50492375-34FD1E9F-24D2-40C2-A310-DFD1EDB7DC95Q53605286-06400528-4C69-4268-8CDC-7447AD0D9AA6Q54277572-965B99E8-0BF5-473B-B2CE-44682F5DE3B8Q55078054-7019518C-EA32-47D1-84CA-1136CC542E19Q57611725-C54261F7-3700-470B-9576-B5992A321BD9
P2860
Mechanistic view of risk factors for venous thromboembolism.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Mechanistic view of risk factors for venous thromboembolism.
@ast
Mechanistic view of risk factors for venous thromboembolism.
@en
Mechanistic view of risk factors for venous thromboembolism.
@nl
type
label
Mechanistic view of risk factors for venous thromboembolism.
@ast
Mechanistic view of risk factors for venous thromboembolism.
@en
Mechanistic view of risk factors for venous thromboembolism.
@nl
prefLabel
Mechanistic view of risk factors for venous thromboembolism.
@ast
Mechanistic view of risk factors for venous thromboembolism.
@en
Mechanistic view of risk factors for venous thromboembolism.
@nl
P2093
P1476
Mechanistic view of risk factors for venous thromboembolism.
@en
P2093
Henri H Versteeg
Pieter H Reitsma
Saskia Middeldorp
P304
P356
10.1161/ATVBAHA.111.242818
P407
P577
2012-03-01T00:00:00Z